Sign In
Buy PEN
$319.37
+0.630 (+0.198%)
At Close: Jun 03, 2026
PEN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Penumbra, Inc. is Fair to Shareholders
08:29am, Thursday, 15'th Jan 2026
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Penumbra, Inc. (NYSE: PEN) to Boston Scientific Corporation for $374.00 in cash or 3.8721
Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments
08:11am, Thursday, 15'th Jan 2026
Penumbra's stock was up about 14% after the deal was announced Thursday morning.
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
07:19am, Thursday, 15'th Jan 2026
Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Boston Scientific to buy Penumbra in deal valued at $14.5 billion
07:07am, Thursday, 15'th Jan 2026
Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion.
Boston Scientific announces agreement to acquire Penumbra, Inc.
07:00am, Thursday, 15'th Jan 2026
Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence of vascular diseases Provides scaled entry into mechanical thrombectomy and neurovascular,
Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results
07:00am, Thursday, 15'th Jan 2026
ALAMEDA, Calif., Jan. 15, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today announced certain unaudited and preliminary financial results for the fourth
Penumbra, Inc. (PEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
04:06am, Tuesday, 13'th Jan 2026
Penumbra, Inc. (PEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
CLPBY vs. PEN: Which Stock Is the Better Value Option?
12:42pm, Monday, 12'th Jan 2026
Investors with an interest in Medical - Instruments stocks have likely encountered both Coloplast A/S Sponsored ADR (CLPBY) and Penumbra (PEN). But which of these two stocks offers value investors a b
Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term
10:50am, Monday, 12'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Penumbra (PEN) is an Incredible Growth Stock: 3 Reasons Why
01:45pm, Wednesday, 07'th Jan 2026
Penumbra (PEN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Penumbra, Inc. (NYSE:PEN) Given Average Rating of “Moderate Buy” by Brokerages
01:44am, Wednesday, 07'th Jan 2026
Shares of Penumbra, Inc. (NYSE: PEN - Get Free Report) have received a consensus rating of "Moderate Buy" from the seventeen ratings firms that are currently covering the stock, MarketBeat reports. On
Here's Why Penumbra (PEN) is a Strong Growth Stock
10:45am, Wednesday, 31'st Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
04:30pm, Monday, 29'th Dec 2025
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 44th Annual J.P. Morgan Healthcare
Reasons to Retain Penumbra Stock in Your Portfolio for Now
08:21am, Friday, 26'th Dec 2025
PEN's expanding thrombectomy portfolio and growing international footprint support momentum, even as FX and macro pressures pose risks.
Stocks At New Highs: Industrials Allient, Wabtec And A Health Care Name Trade In Or Near Buy Zones
04:05pm, Friday, 19'th Dec 2025
Stocks making new highs Friday are industrial sector companies Allient and Wabtec and health technology company Penumbra.
